NasdaqGS - Nasdaq Real Time Price USD
Exelixis, Inc. (EXEL)
36.48
+0.89
+(2.50%)
At close: April 22 at 4:00:01 PM EDT
36.56
+0.08
+(0.22%)
Pre-Market: 5:26:58 AM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
699,971
699,971
333,324
362,614
400,804
Investing Cash Flow
-116,783
-116,783
-26,955
-524,414
-42,884
Financing Cash Flow
-628,808
-628,808
-546,052
586
-14,801
End Cash Position
217,374
217,374
262,994
502,677
663,891
Income Tax Paid Supplemental Data
170,482
170,482
185,658
127,870
12,960
Capital Expenditure
-66,185
-66,185
-162,969
-138,456
-64,225
Repurchase of Capital Stock
-652,033
-652,033
-550,378
--
--
Free Cash Flow
633,786
633,786
170,355
224,158
336,579
12/31/2021 - 4/17/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
INCY Incyte Corporation
57.38
+1.02%
HALO Halozyme Therapeutics, Inc.
58.21
+1.61%
ARGX argenx SE
599.87
+0.70%
CPRX Catalyst Pharmaceuticals, Inc.
22.60
+2.63%
CORT Corcept Therapeutics Incorporated
64.68
+2.83%
BMRN BioMarin Pharmaceutical Inc.
61.50
+4.86%
TGTX TG Therapeutics, Inc.
37.99
+2.76%
ALNY Alnylam Pharmaceuticals, Inc.
236.75
+1.72%
ACAD ACADIA Pharmaceuticals Inc.
14.35
-0.21%
JAZZ Jazz Pharmaceuticals plc
103.38
+3.03%